# Emily J. Goddard

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/emily-j-goddard/

## Facts

| Field | Value |
| --- | --- |
| Citations | 11 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 2 |
| i10-index | 0 |
| Last Known Institution | Adelphi Group (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5102885063 |
| ORCID iD | 0000-0002-1480-040X |
| Works | 7 |

## Researcher papers

- [Three-dimensional Cd( <scp>ii</scp> ) porphyrin metal–organic frameworks for the colorimetric sensing of Electron donors](https://scholariq.org/papers/three-dimensional-cd-scp-ii-scp-porphyrin-metal-organic-frameworks-for-the/)
- [Patient Disease Characteristics and Treatment Patterns in Mild–Moderate Psoriasis: Results from Real-World Clinical Practice in the United States (PROSPECT Study)](https://scholariq.org/papers/patient-disease-characteristics-and-treatment-patterns-in-mild-moderate/)
- [Real-world data in lupus nephritis: results from a European survey on renal function testing and burden of disease progression](https://scholariq.org/papers/real-world-data-in-lupus-nephritis-results-from-a-european-survey-on-renal/)
- [Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme](https://scholariq.org/papers/real-world-experience-with-an-adalimumab-biosimilar-abp-501-in-patients-with/)
- [CO192 Exploring the Value of Total/Near Total Skin Clearance in Patients With a History of Moderate-Severe Psoriasis: A Real-World Survey](https://scholariq.org/papers/co192-exploring-the-value-of-total-near-total-skin-clearance-in-patients-with-a/)
- [Real-World Assessment of Advanced Psoriasis Therapies in the US: Clinical Burden, Treatment Patterns, and Perceptions](https://scholariq.org/papers/real-world-assessment-of-advanced-psoriasis-therapies-in-the-us-clinical-burden/)
- [Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)](https://scholariq.org/papers/patient-characteristics-disease-profile-and-treatment-patterns-in-mild-and/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Metal-Organic Frameworks: Synthesis and Applications](https://scholariq.org/topics/metal-organic-frameworks-synthesis-and-applications/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [Adelphi Group (United Kingdom)](https://scholariq.org/institutions/adelphi-group-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.